| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107419 E.g., Ethyl 2-[2-(4-fluorophenyl)ethyl]-4-(4-{[(2-furylmethyl)amino]carbonyl}phenyl)-5-oxo-8,9-dihydro-5H,7H-pyrazolo[1',2':1,2]pyrazolo[3,4-b]pyridine-3-carboxylate; analogous compounds based on the 7,8,9,9a-tetrahydro-5H-pyrido[2,3-a]pyrrolizine ring; osteoporous; bone disorders; osteoarthritis |
| 05/19/2005 | US20050107418 Macrolides |
| 05/19/2005 | US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 05/19/2005 | US20050107377 3-(Aminoalkoxyphenyl)-substituted, e.g., 1-(4-benzo[b]thiophen-3-yl-phenoxy)-3-benzylamino-propan-2-ol; treatment of conditions such as Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, Parkinson's Disease, Tourette Syndrome and Tardive Diskinesia |
| 05/19/2005 | US20050107375 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 05/19/2005 | US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/19/2005 | US20050107321 FLK-1 is a receptor for vascular endothelial growth factor |
| 05/19/2005 | US20050107310 Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof |
| 05/19/2005 | US20050104042 Process for the synthesis of amine ethers from secondary amino oxides |
| 05/19/2005 | CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/18/2005 | EP1531153A1 Epothilone derivatives |
| 05/18/2005 | EP1530574A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 05/18/2005 | CN1617855A Inhibitors of cytosolic phospholipase A2 |
| 05/12/2005 | WO2005042567A1 Rapamycin peptides conjugates: synthesis and uses thereof |
| 05/12/2005 | WO2005042542A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis |
| 05/12/2005 | WO2005042489A1 N-substituted benzene sulfonamides |
| 05/12/2005 | WO2004089312A3 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 05/12/2005 | WO2004064778A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/12/2005 | US20050101649 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy |
| 05/12/2005 | US20050101626 Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/12/2005 | US20050101624 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 05/12/2005 | US20050101616 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/12/2005 | US20050101598 Crystal structure antibiotic; heating, dissolving, crystallization |
| 05/12/2005 | US20050101596 Such as N,N-dimethyl-3-(phenylsulfonyl)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-amine; for treatment of central nervous system disorders related to or affected by serotonin receptor antagonists such as neurodegenerative disorders, attention deficit disorder, obsessive compulsive disorder, and drug abuse |
| 05/12/2005 | US20050101592 3-(4-chlorophenyl)-2-(2-chlorophenyl)-7-(2,2,2-trifluoroethyl)-6,7-dihydro-2H,5H-4-oxa-1,2,7-triaza-azulen-8-one; for treatment of disorders linked to mediation of cannabinoid receptors |
| 05/12/2005 | US20050101591 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 05/12/2005 | US20050101588 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 05/12/2005 | CA2544731A1 Rapamycin peptides conjugates: synthesis and uses thereof |
| 05/12/2005 | CA2544350A1 N-substituted benzene sulfonamides |
| 05/12/2005 | CA2539335A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis |
| 05/11/2005 | EP1529531A1 Oxadiazolopyrazine derivatives as pharmaceutically active compounds |
| 05/11/2005 | EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 05/11/2005 | CN1615310A Phenyl substituted heterocyclic compounds useful as herbicides |
| 05/11/2005 | CN1615309A Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 05/11/2005 | CN1615303A Improved purification of 4, 4'(5')-di-t-butylcyclohexano-18-crown-6 |
| 05/11/2005 | CN1615299A Xanthine oxidase inhibitors |
| 05/11/2005 | CN1613858A Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 05/11/2005 | CN1200938C Process for preparing 8-methoxy-quinolone |
| 05/11/2005 | CN1200710C New use of macrolide compound |
| 05/10/2005 | US6891038 Provide substantial increase of photoactivation and decoloration rates while retaining high optical density in photoactivated state; used in plastic lenses |
| 05/10/2005 | US6891021 Regulated apoptosis |
| 05/10/2005 | US6890546 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group |
| 05/10/2005 | CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use |
| 05/07/2005 | CA2460384A1 Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 05/06/2005 | WO2005040173A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 05/06/2005 | CA2540817A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 05/05/2005 | US20050096467 Blue 3H-naphtho[2,1-b]pyran compounds and use thereof in photochromic articles |
| 05/05/2005 | US20050096343 pharmocophores of quinolone and oxazolidinone chemicaly linked; against a variety of multi-drag resistant bacteria; staphylococci, enterococci, Moraxella catarrhalis, haemophilus influenza, bacteroides, Clostridia, Mycobacterium tuberculosis, Mycobacterium avium |
| 05/05/2005 | US20050096324 Macrocyclic kinase inhibitors |
| 05/05/2005 | US20050096278 Antibacterial agents |
| 05/04/2005 | EP1527077A2 Pyrrolopyrazines as kinase inhibitors |
| 05/04/2005 | EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | CN1612877A Spiroazacyclic compounds as monoamine receptor modulators |
| 05/04/2005 | CN1199951C Ciprofloxacin mandelate, ofloxacin mandelate and preparation process thereof |
| 05/03/2005 | US6887884 For therapy of neurological and psychological disorders |
| 05/03/2005 | US6887868 Therapeutic 5-HT ligand compounds |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005007630A3 Aryl fused azapolycyclic compounds |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090497 Novel ester or amide derivatives |
| 04/28/2005 | US20050090490 3-Substituted-4-pyrimidone derivatives |
| 04/28/2005 | US20050090483 Purine derivatives as kinase inhibitors |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | US20050090452 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 04/28/2005 | US20050090399 Phenyl substituted with pyrazolone, pyrrolidone, furanone, thiophenone, cyclopentaone, pyranone, 1,3-thiazin-4-one or derivatives thereof; e.g. 8-(2,6-Diethyl-4-methyl-phenyl)-9-(alkenoyloxy)-tetrahydropyrazolo[1,2-d][1,4,5]oxadiazepine-7-one; synergistic mixtures; weeds |
| 04/28/2005 | US20050089982 A hybrid polyketide synthase ("PKS") gene containing a first nucleic acid portion or portions encoding a domain of a first type I PKS, a second nucleic acid portion or portions encoding type I PKS domain which is heterologous to first PKS; Saccharopolyspora species or Streptomyces species as host cell |
| 04/28/2005 | CA2542128A1 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 04/28/2005 | CA2542113A1 Compositions useful as inhibitors of protein kinases |
| 04/27/2005 | EP1526133A1 Epothilone derivatives |
| 04/27/2005 | EP1526132A2 Substituted oxazolidinone derivatives and their use as factor xa inhibitors |
| 04/27/2005 | EP1525192A2 Co-surfactants based on aldehydes |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | EP1034173B1 Method for producing 8-methoxy-quinoline carboxylic acids |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1198827C Selected derivatives of K-252a |
| 04/27/2005 | CN1198506C Herbicidal composition |
| 04/26/2005 | US6884806 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis, periodontal disease, bone disease |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884429 Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
| 04/26/2005 | CA2209487C Imidazo[4,5-c]quinoline amines |
| 04/21/2005 | WO2005035613A1 Process for making amide acetals |
| 04/21/2005 | WO2005035533A1 Modulators of serotonin receptors |
| 04/21/2005 | WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | CA2541086A1 Process for making amide acetals |
| 04/21/2005 | CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/20/2005 | EP1523527A1 Fibre-reactive azo dyes, their preparation and their use |
| 04/20/2005 | EP1523486A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 04/20/2005 | EP1468274A4 Potassium fluoroionophore |
| 04/20/2005 | EP1448547B1 Pyridine derivatives as nmda receptor ligands |
| 04/20/2005 | EP1317460A4 Compounds containing oxazolidinone moiety and uses thereof |
| 04/20/2005 | EP1144395B1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1143977B1 2-oxy-benzoxazinone derivatives for the treatment of obesity |